1Cormican MG,Marshall SA, Jones RN. Detection of extended-spectrum β-lactames (ESBL)-producing strains by the E-test ESBL screen. J Clin Microbiol,1996,34:880-885. 被引量：1
2National committee for clinical Laboratory standards. 2002. Performance Standards for antimicrobial Susceptibility testing Document M100-S10(M7). National committee for clinical Laboratory standards,Wayne,Pa.2002,1.42-49. 被引量：1
3Hirakata Y, Izumikawa K, Yamaguchi T, et al. Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-β-lactamase gene blaIMP. Antimicrob Agents Chemother, 1998,42:2006-2011. 被引量：1
4Poirel L, Naas T, Nicolas D, et al. Characterization of VIM-2, a carbapenem-Hydrolyzing Metallo-β-lactamase and its plasmid-and integron-borne gene from a pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother, 2000,44:891-897. 被引量：2
5Dentton M,Kerr KG.Microbiological and clinical aspects of infection associated with Stenotropomonas maltophilia.Clin Microbiol Rev, 1998;11:57-80. 被引量：2
6Woodford N, Johnson AP. Molecular Bacteriology Protocols and Clinical Applications. Published by HUMANA PRESS, 558-560. 被引量：1
7Vila J, Ruiz J, Navia M, et al.. Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain. J Clin Microbiol,1999,37:758-761. 被引量：1
